Document is current
Any future updates will be listed below
-
Authors
Stanley, Kaitlin J.
Kalbfleisch, Kelsey J.
Moran, Olivia M. https://orcid.org/0000-0002-8134-8345
Chaturvedi, Rajiv R.
Roifman, Maian
Chen, Xin https://orcid.org/0000-0003-1871-4477
Manshaei, Roozbeh
Martin, Nicole
McDermott, Simina
McNiven, Vanda
Myles-Reid, Diane
Nield, Lynne E.
Reuter, Miriam S.
Schwartz, Marci L. B. https://orcid.org/0000-0002-7643-0862
Shannon, Patrick
Silver, Rachel
Somerville, Cherith
Teitelbaum, Ronni
Zahavich, Laura
Bassett, Anne S. https://orcid.org/0000-0002-0681-7279
Kim, Raymond H.
Mital, Seema https://orcid.org/0000-0002-7643-4484
Chitayat, David
Jobling, Rebekah K. https://orcid.org/0000-0003-3596-8161
-
Funding
Funding for this research was provided by:
Ted Rogers Centre for Heart Research
Ted Rogers Centre for Heart Research. RRC is a Rogers’ Innovator in Congenital Heart Disease.
Gouvernement du Canada | Canadian Institutes of Health Research (161429)
Heart and Stroke Foundation of Canada
- License Information
-
More Information
Article History
Received: 6 January 2024
Revised: 28 April 2024
Accepted: 1 May 2024
First Online: 22 May 2024
Competing interests
: The authors report no conflicts of interest. Dr. Mital serves on the Advisory Board of Bristol Myers Squibb and Tenaya Therapeutics.
: This study was approved by the Research Ethics Board at The Hospital for Sick Children (SickKids), Toronto, Ontario, Canada (REB# 1000053844) and the University Health Network, Toronto, Ontario Canada (REB# 16-6282).
